We recently published a list of 10 Stocks Drop The Most Amid Investor Caution. In this article, we are going to take a look ...
The US Food and Drug Administration (FDA) has lifted the clinical hold on ENTR-601-44 and provided authorization to initiate ELEVATE-44-102, a Phase Ib multiple ascending dose (MAD) clinical study of ...
Dyne Therapeutics Inc.-0.93% $1.42B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback